ACTA2 Gene Aortic Aneurysm Familial Thoracic Type 6 Genetic Test
Test Name: ACTA2 Gene Aortic Aneurysm Familial Thoracic Type 6 Genetic Test
Components: ACTA2 gene analysis
Price: 4400.0 AED
Sample Condition: Blood
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Vascular Diseases
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for ACTA2 Gene Aortic Aneurysm, Familial Thoracic Type 6 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ACTA2 Gene Aortic Aneurysm, Familial Thoracic Type 6 NGS Genetic DNA Test gene ACTA2
Test Details:
The ACTA2 gene is associated with a condition called familial thoracic aortic aneurysm, type 6 (FTAAD6). This condition is characterized by the weakening and dilation of the aorta, the main blood vessel that carries oxygenated blood from the heart to the rest of the body. FTAAD6 is an inherited disorder, meaning it can be passed down through families.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes, including the ACTA2 gene. This test can identify mutations or variations in the ACTA2 gene that may be associated with familial thoracic aortic aneurysm type 6. By identifying these genetic changes, NGS testing can help diagnose individuals with FTAAD6 and provide information about their risk of developing aortic aneurysms. It can also be used for genetic counseling and to inform family members about their risk of inheriting the condition.
It’s important to note that a genetic test alone may not be sufficient to diagnose FTAAD6, as other factors such as medical history, physical examination, and imaging tests may also be necessary. Therefore, it is recommended to consult with a healthcare professional or a genetic counselor for a comprehensive evaluation and guidance on genetic testing.
Test Name | ACTA2 Gene Aortic aneurysm familial thoracic type 6 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Vascular Diseases |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ACTA2 Gene Aortic aneurysm, familial thoracic type 6 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ACTA2 Gene Aortic aneurysm, familial thoracic type 6 NGS Genetic DNA Test gene ACTA2 |
Test Details |
The ACTA2 gene is associated with a condition called familial thoracic aortic aneurysm, type 6 (FTAAD6). This condition is characterized by the weakening and dilation of the aorta, the main blood vessel that carries oxygenated blood from the heart to the rest of the body. FTAAD6 is an inherited disorder, meaning it can be passed down through families. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes, including the ACTA2 gene. This test can identify mutations or variations in the ACTA2 gene that may be associated with familial thoracic aortic aneurysm type 6. By identifying these genetic changes, NGS testing can help diagnose individuals with FTAAD6 and provide information about their risk of developing aortic aneurysms. It can also be used for genetic counseling and to inform family members about their risk of inheriting the condition. It’s important to note that a genetic test alone may not be sufficient to diagnose FTAAD6, as other factors such as medical history, physical examination, and imaging tests may also be necessary. Therefore, it is recommended to consult with a healthcare professional or a genetic counselor for a comprehensive evaluation and guidance on genetic testing. |